These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 23430391)

  • 41. Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis.
    Campanholle G; Ligresti G; Gharib SA; Duffield JS
    Am J Physiol Cell Physiol; 2013 Apr; 304(7):C591-603. PubMed ID: 23325411
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The third path of tubulointerstitial fibrosis: aberrant endothelial secretome.
    Lipphardt M; Song JW; Matsumoto K; Dadafarin S; Dihazi H; Müller G; Goligorsky MS
    Kidney Int; 2017 Sep; 92(3):558-568. PubMed ID: 28476555
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fine-tuning vascular fate during endothelial-mesenchymal transition.
    Xiao L; Dudley AC
    J Pathol; 2017 Jan; 241(1):25-35. PubMed ID: 27701751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Interaction of Apelin and FGFR1 Ameliorated the Kidney Fibrosis through Suppression of TGF
    Gao R; Wu Y; Yang Q; Chen L; Chen J; Wang B; Liu Z; Jin J; Li J; Wu G
    Oxid Med Cell Longev; 2023; 2023():5012474. PubMed ID: 36785790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Putative endothelial progenitor cells do not promote vascular repair but attenuate pericyte-myofibroblast transition in UUO-induced renal fibrosis.
    Yang J; Wang M; Zhu F; Sun J; Xu H; Chong Lee Shin OL; Zhao Z; Pei G; Zhu H; Cao C; He X; Huang Y; Ma Z; Liu L; Wang L; Ning Y; Liu W; Xu G; Wang X; Zeng R; Yao Y
    Stem Cell Res Ther; 2019 Mar; 10(1):104. PubMed ID: 30898157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
    Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis.
    Manetti M; Romano E; Rosa I; Guiducci S; Bellando-Randone S; De Paulis A; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2017 May; 76(5):924-934. PubMed ID: 28062404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. microRNA Crosstalk Influences Epithelial-to-Mesenchymal, Endothelial-to-Mesenchymal, and Macrophage-to-Mesenchymal Transitions in the Kidney.
    Srivastava SP; Hedayat AF; Kanasaki K; Goodwin JE
    Front Pharmacol; 2019; 10():904. PubMed ID: 31474862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease.
    Charytan DM; Padera R; Helfand AM; Zeisberg M; Xu X; Liu X; Himmelfarb J; Cinelli A; Kalluri R; Zeisberg EM
    Int J Cardiol; 2014 Sep; 176(1):99-109. PubMed ID: 25049013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Instructive Role of the Microenvironment in Preventing Renal Fibrosis.
    Matsumoto K; Xavier S; Chen J; Kida Y; Lipphardt M; Ikeda R; Gevertz A; Caviris M; Hatzopoulos AK; Kalajzic I; Dutton J; Ratliff BB; Zhao H; Darzynkiewicz Z; Rose-John S; Goligorsky MS
    Stem Cells Transl Med; 2017 Mar; 6(3):992-1005. PubMed ID: 28297566
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular and molecular mechanisms of fibrosis.
    Wynn TA
    J Pathol; 2008 Jan; 214(2):199-210. PubMed ID: 18161745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Mechanism of CD8
    Gao M; Wang J; Zang J; An Y; Dong Y
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A conditionally immortalized Gli1-positive kidney mesenchymal cell line models myofibroblast transition.
    Ó hAinmhire E; Wu H; Muto Y; Donnelly EL; Machado FG; Fan LX; Chang-Panesso M; Humphreys BD
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F63-F75. PubMed ID: 30303712
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac remodeling associated with chronic kidney disease is enhanced in a rat model of metabolic syndrome: Preparation of mesenchymal transition.
    Plawecki M; Gayrard N; Jeanson L; Chauvin A; Lajoix AD; Cristol JP; Jover B; Raynaud F
    Mol Cell Biochem; 2024 Jan; 479(1):29-39. PubMed ID: 36976428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal progenitor cells revert LPS-induced endothelial-to-mesenchymal transition by secreting CXCL6, SAA4, and BPIFA2 antiseptic peptides.
    Sallustio F; Stasi A; Curci C; Divella C; Picerno A; Franzin R; De Palma G; Rutigliano M; Lucarelli G; Battaglia M; Staffieri F; Crovace A; Pertosa GB; Castellano G; Gallone A; Gesualdo L
    FASEB J; 2019 Oct; 33(10):10753-10766. PubMed ID: 31268775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adenovirus-mediated P311 ameliorates renal fibrosis through inhibition of epithelial-mesenchymal transition via TGF-β1-Smad-ILK pathway in unilateral ureteral obstruction rats.
    Qi FH; Cai PP; Liu X; Si GM
    Int J Mol Med; 2018 May; 41(5):3015-3023. PubMed ID: 29436600
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Progenitor-like cells derived from mouse kidney protect against renal fibrosis in a remnant kidney model via decreased endothelial mesenchymal transition.
    Chen CL; Chou KJ; Fang HC; Hsu CY; Huang WC; Huang CW; Huang CK; Chen HY; Lee PT
    Stem Cell Res Ther; 2015 Dec; 6():239. PubMed ID: 26631265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The inhibitory effect of chimeric decoy oligodeoxynucleotide against NF-κB and Sp1 in renal interstitial fibrosis.
    Kim KH; Park JH; Lee WR; Park JS; Kim HC; Park KK
    J Mol Med (Berl); 2013 May; 91(5):573-86. PubMed ID: 23114611
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role played by perivascular cells in kidney interstitial injury.
    Rojas A; Chang FC; Lin SL; Duffield JS
    Clin Nephrol; 2012 May; 77(5):400-8. PubMed ID: 22551886
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sources of myofibroblasts in kidney fibrosis: all answers are correct, however to different extent!
    Ballhause TM; Soldati R; Mertens PR
    Int Urol Nephrol; 2014 Mar; 46(3):659-64. PubMed ID: 24368748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.